Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0N6IG
|
||||
Former ID |
DIB002307
|
||||
Drug Name |
H3 receptor inverse agonists
|
||||
Synonyms |
H3 receptor inverse agonists (CNS disorders, obesity); H3 receptor inverse agonists(CNS disorders, obesity), Roche
|
||||
Indication | Central nervous system disease [ICD10:G00-G99] | Investigative | [552077] | ||
Company |
F Hoffmann-La Roche Ltd
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
C(=O)(c1n(c2c(c1)cc(cc2)OC1CCN(CC1)C(C)C)C(C)C)N1CCC(CC<br />1)(F)F
|
||||
Target and Pathway | |||||
Target(s) | Histamine H3 receptor | Target Info | Agonist | [543673] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.